Characterization of a novel T cell activating protein in arthritis
关节炎中新型 T 细胞激活蛋白的表征
基本信息
- 批准号:8212554
- 负责人:
- 金额:$ 14.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultApoptoticArchitectureArthritisBirthBone DensityCartilageCellsComputersDevelopmentDiseaseEmbryonic DevelopmentFollistatinFollistatin-Related Protein 1Gene TransferHealthHumanIL2RA geneInflammationInflammatoryInflammatory ResponseInterferonsInterleukin-1Interleukin-12Interleukin-17Interleukin-2JointsMediatingMediator of activation proteinMonoclonal AntibodiesMusOsteoblastsOsteoclastsOsteocytesOsteogenesisPhenotypePhysiologyPlayProductionPropertyProteinsRheumatoid ArthritisRoleSignal TransductionStructureT-Cell ActivationT-Cell DepletionT-LymphocyteTimeWild Type MouseX-Ray Computed Tomographybonebone strengthcytokinejoint destructionmineralizationmouse modelnovelprotein structurereceptorresponsetomographytool
项目摘要
DESCRIPTION (provided by applicant): We have discovered that a novel protein, follistatin-like-1 (FSTL-1), is highly expressed in the joints of mice and humans with arthritis, especially at the interface of synovial pannus and eroding bone. A key role for FSTL- 1 in arthritis progression was confirmed by suppression of disease by FSTL-1 neutralization. Our studies indicate that FSTL-1 is a co-stimulator of T cells. We will characterize FSTL-1 and its contribution to inflammatory arthritis in mouse models of disease, with detailed study of T cell activation. The first Aim is to determine the role of FSTL-1 in the normal joint. Our studies demonstrate that FSTL-1 is produced at low levels in the adult mouse joint. FSTL-1 is induced in osteoblasts by TGF-2, a key bone regulatory factor, and FSTL-1 is an arthritis progression factor, but the role of FSTL-1 in normal bone and joint physiology is not characterized. We will determine the cells responsible for FSTL-1 production within the joint during embryogenesis and post-natal development. We will characterize the role of FSTL-1 using a new FSTL-1 hypomorphic (knockdown) mouse by assessing the effect of FSTL-1 under-expression on joint structure at birth and during development to adulthood, bone formation and architecture, bone density and strength, and cartilage integrity. The second Aim is to determine the contribution of FSTL-1 to arthritis. FSTL-1 is induced by IL-12 and FSTL-1 is increased in arthritic joints, where it plays a pro-inflammatory role. These findings suggest that bone is not solely a target of arthritis, but plays an active role in joint destruction. We will characterize the contribution of bone to arthritis progression, focusing on FSTL-1 as a mediator. FSTL-1 will be over-expressed by gene transfer, under-expressed using the FSTL-1 hypomorphic mouse, and neutralized at various times during arthritis using anti-FSTL-1 monoclonal antibody. We will compare the effects of varying FSTL-1 expression on the inflammatory pannus, cartilage and bone formation and erosion, bone formation rate by dynamic histomorphometry, changes in mineralization by micro computer tomography, changes in osteoclastic activity and matrix cells, and expression of pro-inflammatory cytokines induced in response to FSTL-1. The third Aim is to determine how FSTL-1 activates T cells and induces IFN-3 secretion. FSTL-1 promotes inflammation by enhancing IFN-3 signaling. The inflammatory response is dependent on T cells, as T cell depletion abolishes FSTL-1-induced paw inflammation. Furthermore, FSTL-1 prolongs expression of the T cell activation molecule, CD25. To characterize the T cell activating properties of FSTL-1, we will determine the T cell activation phenotype induced by FSTL-1, whether FSTL-1 stabilizes TCR mediated signaling by inducing anti-apoptotic molecules, whether FSTL-1 stimulates T cells directly or indirectly, the receptor for FSTL-1, the protein structure necessary for FSTL-1 activity, and whether FSTL-1 has additional actions on inflammation. Characterization of FSTL- advance understanding of arthritis and may provide new treatment options. PUBLIC HEALTH RELEVANCE: studies will characterize the role in arthritis and joint development of a novel mediator of arthritis progression, FSTL-1. Characterization of FSTL-1 will advance understanding of arthritis and may provide new treatment options.
描述(由申请人提供):我们发现一种新的蛋白质卵泡抑素样-1(FSTL-1)在患有关节炎的小鼠和人类的关节中高度表达,特别是在滑膜血管翳和侵蚀骨的界面处。通过FSTL-1中和抑制疾病证实了FSTL- 1在关节炎进展中的关键作用。我们的研究表明FSTL-1是T细胞的共刺激分子。我们将在小鼠疾病模型中描述FSTL-1及其对炎症性关节炎的作用,并详细研究T细胞活化。第一个目的是确定FSTL-1在正常关节中的作用。我们的研究表明,FSTL-1在成年小鼠关节中以低水平产生。FSTL-1在成骨细胞中由关键骨调节因子TGF-2诱导,并且FSTL-1是关节炎进展因子,但FSTL-1在正常骨和关节生理学中的作用尚未表征。我们将确定在胚胎发生和出生后发育过程中负责关节内FSTL-1产生的细胞。我们将使用新的FSTL-1亚型(敲低)小鼠,通过评估FSTL-1表达不足对出生时和发育至成年期关节结构、骨形成和结构、骨密度和强度以及软骨完整性的影响,来表征FSTL-1的作用。第二个目的是确定FSTL-1对关节炎的贡献。FSTL-1由IL-12诱导,并且FSTL-1在关节炎关节中增加,在关节炎关节中起促炎作用。这些发现表明,骨不仅是关节炎的目标,而且在关节破坏中起着积极的作用。我们将描述骨对关节炎进展的贡献,重点是FSTL-1作为中介。FSTL-1将通过基因转移过表达,使用FSTL-1亚型小鼠低表达,并在关节炎期间的不同时间使用抗FSTL-1单克隆抗体中和。我们将比较不同的FSTL-1表达对炎性血管翳,软骨和骨形成和侵蚀,骨形成率的动态组织形态计量学,矿化的变化,微计算机断层扫描,骨形成活性和基质细胞的变化,和促炎细胞因子的表达诱导响应FSTL-1的影响。第三个目的是确定FSTL-1如何激活T细胞并诱导IFN-3分泌。FSTL-1通过增强IFN-3信号传导促进炎症。炎症反应依赖于T细胞,因为T细胞耗竭消除了FSTL-1诱导的爪炎症。此外,FSTL-1抑制T细胞活化分子CD 25的表达。为了表征FSTL-1的T细胞活化特性,我们将确定FSTL-1诱导的T细胞活化表型,FSTL-1是否通过诱导抗凋亡分子稳定TCR介导的信号传导,FSTL-1是否直接或间接刺激T细胞,FSTL-1的受体,FSTL-1活性所需的蛋白质结构,以及FSTL-1是否对炎症具有额外的作用。FSTL的表征-推进对关节炎的理解,并可能提供新的治疗选择。公共卫生相关性:研究将描述关节炎进展的新型介质FSTL-1在关节炎和关节发育中的作用。FSTL-1的表征将促进对关节炎的理解,并可能提供新的治疗选择。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raphael Hirsch其他文献
Raphael Hirsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raphael Hirsch', 18)}}的其他基金
The Child Health Research Career Development Program at UCSF
加州大学旧金山分校儿童健康研究职业发展计划
- 批准号:
10610824 - 财政年份:2021
- 资助金额:
$ 14.25万 - 项目类别:
The Child Health Research Career Development Program at UCSF
加州大学旧金山分校儿童健康研究职业发展计划
- 批准号:
10224603 - 财政年份:2021
- 资助金额:
$ 14.25万 - 项目类别:
The Child Health Research Career Development Program at UCSF
加州大学旧金山分校儿童健康研究职业发展计划
- 批准号:
10374909 - 财政年份:2021
- 资助金额:
$ 14.25万 - 项目类别:
USE OF THERMAL AND 3D IMAGING TO QUANTIFY ARTHRITIS
使用热成像和 3D 成像来量化关节炎
- 批准号:
7567325 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
USE OF THERMAL AND 3D IMAGING TO QUANTIFY ARTHRITIS
使用热成像和 3D 成像来量化关节炎
- 批准号:
7806547 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
Characterization of a novel T cell activating protein in arthritis
关节炎中新型 T 细胞激活蛋白的表征
- 批准号:
7774332 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
Characterization of a novel T cell activating protein in arthritis
关节炎中新型 T 细胞激活蛋白的表征
- 批准号:
7624847 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
Characterization of a novel T cell activating protein in arthritis
关节炎中新型 T 细胞激活蛋白的表征
- 批准号:
8435422 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
Characterization of a novel T cell activating protein in arthritis
关节炎中新型 T 细胞激活蛋白的表征
- 批准号:
8495522 - 财政年份:2009
- 资助金额:
$ 14.25万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10538071 - 财政年份:2022
- 资助金额:
$ 14.25万 - 项目类别: